TLC Biopharmaceuticals, Inc.
601 Gateway Boulevard
South San Francisco
5 articles with TLC Biopharmaceuticals, Inc.
12/2/2019Even with a shortened week due to the U.S. Thanksgiving holiday, there was plenty of clinical trial news and updates. Here’s a look.
10/28/2019Although the clinical trial news last week was dominated by the stunning reversal of Biogen and Eisai’s clinical trials of aducanumab for Alzheimer’s disease, there was plenty of other trial news. Here’s a look.
It was another busy week for clinical trials. Here’s a look.
The new partnership’s efforts will take place pursuant to recent reforms by the CFDA, which include initiatives designed to accelerate drug approvals and encourage innovation, including greater alignment of China's review process with that of the US and the EU.
TLC Biopharmaceuticals, Inc. Reports Results Of Phase 1/2 Clinical Trial Of TLC599 For Sustained Pain Relief In The Treatment Of Osteoarthritis Of The Knee